Skip to main content
. 2022 Jan 3;2022:5728408. doi: 10.1155/2022/5728408

Figure 7.

Figure 7

The model of molecular docking. (A) AKTI-(2R)-5,7-dihydroxy-2-(4-hydroxyphenyl)chroman-4-one; (B) AKTI-arachidonic acid; (C) AKT1-isorhamnetin; (D) AKT1-quercetin; (E) AKT1-kaempferol; (a) EGFR-(2R)-5,7-dihydroxy-2-(4-hydroxyphenyl)chroman-4-one; (b) EGFR-arachidonic acid; (c) EGFR-isorhamnetin; (d) EGFR-quercetin; (e) EGFR-kaempferol.